Nipro 

$9.61
5
-$0.36-3.56% Tuesday 18:54

Statistics

Day High
9.69
Day Low
9.67
52W High
9.96
52W Low
8.23
Volume
400
Avg. Volume
8
Mkt Cap
1.65B
P/E Ratio
43.32
Dividend Yield
0.66%
Dividend
0.06

Upcoming

Dividends

0.66%Dividend Yield
Mar 26
$0.11
Dec 25
$0.07
Jun 25
$0.09
Dec 24
$0.08
Jun 24
$0.1
10Y Growth
1.55%
5Y Growth
-2.64%
3Y Growth
14.81%
1Y Growth
21.74%

Earnings

7MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.1
0.05
0.2
0.35
Expected EPS
0.0455927574189402
Actual EPS
N/A

Financials

0.79%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
8.69BRevenue
68.25MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NPRRF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic is a global leader in medical technology, services, and solutions, competing directly with Nipro in the medical device sector, particularly in areas like diabetes management and dialysis.
Baxter International
BAX
Mkt Cap9.49B
Baxter International develops, manufactures, and markets products that save and sustain the lives of people, similar to Nipro's offerings in renal care and medical products.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices that are used in a range of interventional medical specialties, competing with Nipro in various healthcare solutions.
Fresenius Medical Care
FMS
Mkt Cap15.87B
Fresenius Medical Care is a leading provider of dialysis services and products, making it a direct competitor to Nipro's dialysis segment.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, competing with Nipro in areas such as medical devices and diagnostics.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a comprehensive healthcare firm that offers products and services in pharmaceuticals, medical devices, and consumer health, competing across multiple segments with Nipro.
Danaher
DHR
Mkt Cap152.13B
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities, and trauma products; competing in the medical device market with Nipro.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical devices and equipment, offering products in orthopaedics, medical and surgical, and neurotechnology and spine, which competes with Nipro's medical device offerings.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents, competing with Nipro in the healthcare and medical product sectors.

About

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations. The company's Pharma Packaging business offers glass vials, ampoules, syringes, and cartridges; glass tubes; glass forming machinery; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.
Show more...
CEO
Mr. Yoshihiko Sano
Employees
36259
Country
JP
ISIN
JP3673600007

Listings

0 Comments

Share your thoughts

FAQ

What is Nipro stock price today?
The current price of NPRRF is $9.61 USD — it has decreased by -3.56% in the past 24 hours. Watch Nipro stock price performance more closely on the chart.
What is Nipro stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nipro stocks are traded under the ticker NPRRF.
What is Nipro market cap?
Today Nipro has the market capitalization of 1.65B
When is the next Nipro earnings date?
Nipro is going to release the next earnings report on May 07, 2026.
What were Nipro earnings last quarter?
NPRRF earnings for the last quarter are 0.42 USD per share, whereas the estimation was 0.19 USD resulting in a +118.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nipro revenue for the last year?
Nipro revenue for the last year amounts to 8.69B USD.
What is Nipro net income for the last year?
NPRRF net income for the last year is 68.25M USD.
Does Nipro pay dividends?
Yes, NPRRF dividends are paid semi-annual. The last dividend per share was 0.11 USD. As of today, Dividend Yield (FWD)% is 0.66%.
How many employees does Nipro have?
As of April 01, 2026, the company has 36,259 employees.
When did Nipro complete a stock split?
The last stock split for Nipro was on September 28, 2011 with a ratio of 2:1.
Where is Nipro headquartered?
Nipro is headquartered in Osaka, JP.